How This Zika Stock Is Going To Explode (2016)

If you have been living in your mom’s basement, the Zika virus is the next widespread outbreak of diseases after the swine flu (H1N1), the bird flu and Ebola. Even WHO is forecasting a potential 3 million to 4 million cases of the virus as it spreads to 23 countries in America only. Canada’s first case of the virus and two new cases in Arkansas have been confirmed just yesterday.

Obama asks Congress for $1.8 billion to combat spread of Zika virus

Why I think BioCryst (NASDAQ: BCRX) is going nowhere, but up

BioCryst Pharmaceuticals Inc. have been creating many antivirals widely known to stop several epidemics, such as H1N1 and Ebola (BCX4430). BioCryst has previously been approved by FDA for the H1N1 vaccine.

NASDAQ: BCRX (since IPO)

With BioCryst announcing a promising potential Zika threatment, I am 100% positive that this stock will rise up until $10–$20 range from $1-$3.

(BCRX is currently trading at $3.42 at the time of this writing)

DISCLAIMER: This article is for educational purposes only. I am not responsible for any losses.

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.